To circumvent this challenge, molecular docking study was first conducted using 313 curated bioactive compounds on target proteins [e.g., IDH2 protein (Table 3)] implicated in cancer pathogenesis (Egbuna et al., 2021; Egbuna et al., 2023). Here, IDH2 is linked to cancer.